Thermo Fisher Scientific Inc. closed $67.09 below its 52-week high ($627.88), which the company achieved on September 10th.

Thermo Fisher Scientific's third-quarter profit declined and revenue missed estimates as its two biggest divisions struggled.

Thermo Fisher Scientific and Novo Nordisk Foundation Cellerator have partnered to shape the future of cell manufacturing at a newfound innovation hub ...

Thermo Fisher Scientific Inc. closed $81.56 short of its 52-week high ($627.88), which the company achieved on September 10th ...

On Wednesday, Thermo Fisher Scientific Inc. (NYSE: TMO) posted third-quarter revenue of $10.59 billion, almost flat year over ...

Thermo Fisher Scientific Inc.'s Q3 results demonstrated some end-market stability, particularly in the life science market.

Thermo Fisher Scientific on Wednesday raised the lower end of its annual profit forecast, tweaking it for the third time this ...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Thermo Fisher Scientific fair value estimate is US$800 ...

On Tuesday, Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $547.77 which represents a decrease of $-4.77 or -0.86% from the prior close of $552.54. The stock opened at $550.

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) had its price objective decreased by investment analysts at Barclays ...

Mount Yale Investment Advisors LLC lessened its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 23.0% ...

Thermo FisherScientific has announced the signing of a Memorandum of Understanding (MoU) with the Government of Telangana to ...